New Technique Promises Improved Metastatic Prostate Cancer Detection

  Prostate cancer is the second-leading cause of male cancer deaths worldwide. Deaths from prostate cancer are primarily due to metastasized cancer, in which cancer cells have migrated through the body and begun to grow in other areas. Results reported in Biomicrofluidics, from AIP Publishing, promise a new way to detect this deadly disease through a simple, inexpensive device. The...Read More

Protein that hinders advancement of prostate cancer identified

  Researchers at Boston University School of Medicine (BUSM) have discovered that blocking a specific protein, may be a promising strategy to prevent the spread of castration-resistant prostate cancer (CRPC). Under the direction of BUSM's Gerald V. Denis PhD, researchers have long studied a family of three closely related proteins, called BET bromodomain proteins, composed of BRD2, BRD3 and BRD4,...Read More

The 4Kscore Test to Identify the Risk of Aggressive Prostate Cancer

  Better biomarkers that can discriminate between aggressive and indolent phenotypes of prostate cancer are urgently needed. In the first 20 years of the prostate-specific antigen (PSA) era, screening for prostate cancer has successfully reduced prostate cancer mortality, but has led to significant problems with overdiagnosis and overtreatment. As a result, many men are subjected to unnecessary prostate biopsies and...Read More

Testing For C-reactive Protein May Save Your Life

  Have you had your CRP levels tested? You should—because this simple blood test might just save your life. C-reactive protein, or CRP, has long been used as a marker of inflammation in the body.1High CRP levels are found in practically every known inflammatory state. Even if you have no symptoms of disease, elevated CRP levels may signal an increased risk for practically all degenerative...Read More